Table II. Diagnosis of patients in this study according to mutation status.
SF3B1: Splicing factor 3B subunit 1; TET2: tet methylcytosine dioxygenase 2. AML: acute myeloid leukemia; MDS: myelodysplastic syndrome; MPN: myeloproliferative neoplasm. Other: One patient with therapy-related myeloid neoplasm, four with aplastic anemia, and 12 with bone marrow with no obvious morphological abnormalities. abSignificantly different from TET2.